These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11955404)

  • 1. [Treatment of organ transplant rejection with low doses of CsA and CTLA4-Ig].
    Qian Y; Chen G; Huang J
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):150-2. PubMed ID: 11955404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
    Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.
    Bolling SF; Lin H; Wei RQ; Linsley P; Turka LA
    J Surg Res; 1994 Jul; 57(1):60-4. PubMed ID: 8041150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of combined application of external cyclosporine A and CTLA4Ig on the survival of rat auricle allograft].
    Cao C; Li SR; Sun ZC; Wang ZX; Luo GX; Wu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jul; 16(4):281-3. PubMed ID: 12181799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model.
    Wu SL; Pan CE; Yu L; Meng KW
    Transplant Proc; 2005 Jun; 37(5):2354-9. PubMed ID: 15964415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection].
    Dong Y; Huang YF; Wang LQ; Chen B
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.
    Kimura F; Gotoh M; Tanaka T; Luo Z; Miyazaki J; Uede T; Monden M; Miyasaka M
    Diabetologia; 2002 Jun; 45(6):831-40. PubMed ID: 12107727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors.
    Fernandes JR; Duvivier-Kali VF; Keegan M; Hollister-Lock J; Omer A; Su S; Bonner-Weir S; Feng S; Lee JS; Mulligan RC; Weir GC
    Transpl Immunol; 2004 Nov; 13(3):191-200. PubMed ID: 15381202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance and expresssion of fractalkine in acute rejection after rat orthotopic liver transplantation].
    Meng K; Song Z; Zhou X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):528-31. PubMed ID: 17578296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract]   [Full Text] [Related]  

  • 15. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific transfusions enhance the immunosuppressive effects of single-dose cyclosporine A and CTLA4-Ig but do not result in long-term graft acceptance in a histoincompatible model of rat lung allograft rejection.
    Jordan SC; Matsumara Y; Zuo XJ; Marchevsky A; Linsley P; Matloff J
    Transpl Immunol; 1996 Mar; 4(1):33-7. PubMed ID: 8762006
    [No Abstract]   [Full Text] [Related]  

  • 17. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocytic infiltration or transcription of key cytokines.
    Matsumura Y; Zuo XJ; Prehn J; Linsley PS; Marchevsky A; Kass RM; Matloff JM; Jordan SC
    Transplantation; 1995 Feb; 59(4):551-8. PubMed ID: 7533346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.